BRCA1- and BRCA2-deficient breast cancers were shown to be associated with elevated proportion of signature 3, suggesting an underlying deficiency in homologous recombination repair, and by extension, higher degree of genomic instability in these groups of breast cancers. This evidence concerns the gene BRCA2 and breast carcinoma.